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Abstract Secretogranin II (Sgll) is an acidic secretory protein 
present in large dense core vesicles of neuronal and endocrine 
cells. Based on the sequence of a peptide derived from the 
processing of SgII in the brain of the frog Rana ridibunda, 
degenerate oligonucleotides were used to clone the cDNA 
encoding frog SgII from a pituitary cDNA library. This cDNA 
encodes a 574 amino acid protein which exhibits 46-48% 
sequence identity with mammalian SglI and contains 11 pairs 
of basic amino acids. Four potential processing products 
delimited by pairs of basic residues exhibited a much higher 
degree of identity (68--82%) with the corresponding mammalian 
SgII sequences. The frog SgII mRNA is ,--4 kb in length and is 
differentially expressed in the brain and endocrine tissues. The 
present data reveal that several SgII-derived peptides have been 
highly conserved uring evolution, suggesting that these peptides 
may play important neuroendoerine r gulatory functions. 
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1. Introduction 
Secretogranin II (SglI) is a member of a family of acidic 
secretory proteins called 'granins' which also includes chro- 
mogranin A (CgA) and chromogranin B (CgB) [1]. Granins 
are characterized by their high content of acidic amino acids, 
their localization in secretory organelles of endocrine cells and 
neurons, and the presence in their sequences of multiple pairs 
of basic residues which represent potential cleavage sites for 
processing enzymes [2,3]. 
In addition to a proposed role in the formation of secretory 
granules in neuronal and endocrine cells, the granins may 
serve as precursors for biologically active peptides [1 3]. In 
particular, Sgll contains nine pairs of  basic amino acids in all 
mammalian species studied so far, some of which are actually 
cleaved to generate shorter peptides [4,5]. In fact, several pep- 
tides derived from the proteolytic processing of SglI have 
already been isolated and characterized from the brain or 
endocrine tissues [6--8]. For instance, we have previously iden- 
tified a 33-amino acid peptide arising from the proteolytic 
cleavage of SglI from the brain of the frog Rana ridibunda 
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[6]. A homologous peptide, named secretoneurin (SN), has 
been subsequently identified in the brain and various endo- 
crine tissues in mammals [9]. Functional studies revealed that 
SN stimulates dopamine release in the rat striatum [10,11] and 
triggers migration of human monocytes in vitro [12] thus es- 
tablishing SN as an authentic regulatory neuropeptide. 
Although SN has been initially isolated from the frog brain, 
the primary structure of frog SglI has not been characterized 
and therefore the phylogenetic onservation of this granin 
throughout vertebrates i still unknown. We now report the 
cloning of the cDNA encoding SglI in the frog Rana ridibunda 
and its expression in the brain and endocrine tissues. 
2. Materials and methods 
2.1. PCR, cloning and sequencing 
A frog (Rana ridibunda) pituitary cDNA library (9.6 × 10 6 recombi- 
nants) was constructed in the plasmid CDM7/amp (T.B. Usdin, La- 
boratory of Cell Biology, NIMH, NIH) [13] and used in a PCR 
reaction to amplify the DNA fragment corresponding to the frog 
SN sequence. The PCR was carried out in a 50-1al volume containing 
67 mM Tris-HC1, pH 8.8, 16 mM (NH4)2SO4, 2.5 mM MgCI2, 0.01% 
Tween 20, 200 ~tM of each dNTP, 1 laM of degenerate s nse primer 
FSG1, 5'-AA(CIT)GA(AIG)AT(AITIC)GT(AIGICIT)GA(AIG)GG-3' 
and antisense primer FSG2, 5'-TT(AIG)TT(GIAIT)GC(CIT)TG(GITI 
C)CC(C/T)TT-3' corresponding respectively to the hexapeptide se- 
quences NEIVEG and KGQANN of the frog SN extremities [6], 
240 ng of the frog pituitary cDNA library and 2.5 units Taq DNA 
polymerase (Eurobio) in a Robocycler Gradient 40 (Stratagene). After 
4 min of denaturation at 94°C, 45 cycles of amplification were per- 
formed with denaturation at94°C for 1 rain, annealing at 40°C for 1.5 
min and extension at 72°C for 1.5 min, followed by an additional 
extension at 72°C for 7 min. The PCR products were analyzed by 
electrophoresis in 1.8% agarose gel and two bands with a size -<125 
bp (corresponding to the lower size marker used) were purified and 
ligated into the pGEMT vector (Promega). Sequencing showed that 
one of these bands corresponded to the DNA sequence ncoding frog 
SN. This sequence was used to design a homologous antisense oligo- 
nucleotide, SN1, 5'-GAGTTCCTGGAAGACAGACTGTAAGGTG- 
GCTAGGCTCTGAGGAGTATA-3', which was used as a primer 
along with a T7 primer (present in the cDNA library vector) in a 
second PCR reaction in order to amplify the 5' region of frog SgII 
from the library. The PCR conditions were as above, except hat 1.5 
mM MgCI~ was used and 30 cycles of denaturation at94°C for 1 min, 
annealing at 55°C for 2 min and extension at 72°C for 2 min were 
performed. The DNA fragment obtained, RFSN3, was inserted into 
the pGEMT vector and partially sequenced to verify that it actually 
corresponded to the SgII cDNA sequence. 
2.2. Cloning of the full-length frog SgH cDNA 
The DNA fragment RFSN3 was labeled by random-priming (On- 
cor) and used to screen 105 recombinants of the frog cDNA library. 
Several positive clones were obtained and their inserts were character- 
ized by restriction mapping and Southern blotting analysis. Restric- 
tion fragments of the positive clone FSG82 with a ~3.8 kb insert 
were subcloned into pBluescript II KS (Stratagene) and sequenced on 
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both strands with T7, T3 and internal primers using the Sequenase kit
(Amersham). The junctions between the fragments were confirmed by 
sequencing the corresponding regions on the full-length clone FSG82 
using internal primers. 
2.3. Northern blot analysb 
Total RNA from frog tissues was prepared by the acid guanidinium 
thiocyanate-phenol-chloroform method [14] using the Trizol reagent 
(Life Technologies). Equivalent amounts of RNA (20 p.g) were ana- 
lyzed as described previously [15] and hybridized to 32p-labeled ran- 
dom-primed RFSN3 containing the 5' region of frog SglI. Hybridiza- 
tion was performed at 42°C and the blot washed at 50°C in standard 
conditions [16]. 
2.4. In situ histochemical hybridization 
Frogs were anesthetized and perfused transcardially with 4% par- 
aformaldehyde. Frontal sections (12 lam) of post-fixed and embedded 
brains were cut in a cryostat and kept at -80°C until use. Tissue 
sections were hybridized at 60°C in the presence of 107 cpm/ml 35S- 
labeled riboprobe as previously described [17]. Sense and antisense 
riboprobes were prepared by in vitro transcription ofan EeoRI-Hin- 
dIII fragment (containing bases 1-738 of FSG82) subcloned into 
pBluescript II KS, in the presence of [35S]UTP (Amersham) and T7 
or T3 RNA polymerase [18]. After hybridization, tissue slices were 
dehydrated and exposed onto Hyperfilm !3 max (Amersham) for 
2 days. The slides were subsequently dipped into Kodak NTB-2 liquid 
emulsion at 40°C, exposed for 15 days and developed. In order to 
identify anatomical structures, the brain sections were stained with 
hematoxylin and eosin. 
3. Results and discussion 
3.1. Cloning and characterization of  the frog SgH cDNA 
Since in mammals the SgII gene is actively expressed in the 
pituitary [19], the cloning of the frog SgII cDNA was per- 
formed using a frog pituitary library, even though frog SN 
was initially characterized from the frog brain [6]. Degenerate 
oligonucleotides deduced from the sequence of frog SN were 
used to amplify by PCR the cognate DNA sequence from a 
Rana ridibunda pituitary library. A product of the PCR reac- 
tion gave the expected sequence encoding the frog SN peptide 
(data not shown). This sequence was then used to synthesize a 
homologous oligonucleotide in order to amplify the 5' region 
of the frog SglI cDNA from the library by means of a 5' 
RACE reaction (data not shown). The PCR product (,~ 600 
bp) was used as a probe to screen the library for full-length 
SgII cDNA clones. This approach was chosen rather than 
screening the library with the homologous oligonucleotide in 
order to increase the probability of isolating full-length 5' 
region-containing clones. Screening of the cDNA library 
with the 5' RACE product led to the isolation of several 
clones with inserts ranging between 1.6 and 3.8 kb. The large 
size of the majority of the clones isolated was intriguing in- 
asmuch as the mammalian SgII encoding mRNA is ,~ 2.5 kb 
in length [2]. Sequencing of the longest clone revealed an open 
reading frame of 1803 bp encoding a 601 amino acid protein. 
Most of the extra sequences lay in the Y-untranslated region 
of the cDNA (Fig. 1 and data not shown). The first 27 amino 
acids of the encoded protein correspond to a putative signal 
peptide based on the conservation of the cleavage site found 
in mammalian SgII [20], and the remaining 574 amino acids 
represent the mature frog SgII protein with a deduced molec- 
ular weight of 67001 Da. This protein contains a putative 
tyrosine sulfation site at position 124 surrounded by acidic 
amino acids homologous to the tyrosine sulfation site found 
in mammalian SgII [2], and a potential N-glycosylation site at 
position 280 (Fig. 1). 
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Another important structural feature shared with mamma- 
lian SgII is the high content of acidic amino acids in the frog 
protein with 20% of its residues being either aspartic acids or 
glutamic acids. The high proportion of acidic residues ug- 
gests that frog SgII, like its mammalian counterpart [21], 
may play a role in the formation of secretory granules and/ 
or in the packaging of their resident neuropeptides and pep- 
tide hormones [1-3]. 
3.2. SgH as a propeptide protein 
Characterization f the primary structure of SgII in mam- 
5 ' CACGGGAGATATGAT CAGCCTGCAT CCCT CT GACTGAAGCACACAGGAAACACTGACG 58 
ACCATGT CATCT CAGAGGAAT ACTGT CT TGCAGGATGCTTAT CCT CATGCATT T TGGT C 118 
M S S Q R N Y C L A G C L S S C I L V -19 
AT CCTAATGT CCTT T T CTGATGC TGCAT C CT T T CAATAT T ACCAAGT GCCACAACAGGAC 178 
I L M S F S D A ,~  S F Q Y Y Q V P Q Q D 12 
CAAGAATATAGAATGAAGACT T GCAAAGGT GCCAAG CCCTGATAT GCTGAAGGCACTA 238 
Q E Y R M K T L Q R L P S P D M L K A L 32 
GAGTACAT TGAGAAT CT CAGGAAGCAAGCAAGCAGAACTGAGAGCCT CCCCGACTATACC 298 
E Y I E N L R_.._~K Q A S R T E S L P D Y T 52 
T CT TACCAA~CACCCT T CCT CT CAGAACAGAAGGACACACAAGCCCT TTCAACAGAC 358 
8 Y Q G A P F L S E Q K D T Q A L S T D 72 
ACTGC CAAAT CT CCAACCAGCGATGATGAATCTGAGTGGATGAGAGCAATGT TG AAGCC 418 
T A K S P T S D D E S E W M R A M L E A 92 
T TGATGCAAGCTGAAAAAGAGGCAAAGGTT T CAC CACAAGAGAAAAATAAT CTATACATG 478 
L M Q A E K E A K V S P Q E K N N L Y M 112 
GACAAGAACATACCACCTGAGT TAAT T GAAGATTATGACT CAAACAAATGGT CTGAGAAG 538 
D K N I P P E L I E D (~) D S N K W S E K 132 
AGACCTAAAGCTGGAAAAT T T CT T CAAGGT TATATGATGACTACTCACGGGACAAT CCA 598 
R_ P K A G K F S S R L Y D D Y S R D N P 152 
CTGAAGCGCACAAATGAAATTGTGGAAE43GCAGTATACT CCT CAGAGCCTAGCCACCTTA 658 
L K R T N E I V E G Q Y T P Q S L A T L 172 
C AGT CT GT C T T C CAGGAA C T GGGGAAAT  AAAAGGCCAAGCAAACAACAAGAGAGATAGA 718 
Q S V F Q E L G K L K G Q A N N KR D R 192 
ATGGAAGAAGACCAAAAGCT T ACAAGGATGATGAAGATGACT TGTATAAAGCCAACAAC 778 
M E E D Q K L Y K D D E D D L Y K A N N 212 
AT TGCT TATGAGGATGTAGCTGGT~AAGATTGGAAT CCTAT TGAAGAAAAAGT GAA 838 
I A Y E D V A G G E D W N P I E B K V E 232 
AGT CAAACT CAAGAAGAGT AAAGGAGAG TAAAGAGGAGGTTGAGAAGACAGATGATAT G 898 
S Q T Q E E L K E S K E E V E K T D D M 252 
GAGGAT GAAATAAAGAGAT CTGGGT TGTT ~ T  TGCAGGAT GAAGAGCCTGAAAAAGAC 958 
E D E I MR S G L L G L Q D E E P E K D 272 
ACTAAAGAGCAAGAAAGTGAAAAT CTAT CAAATCTGATGAACACATAT CTAAACATGTGG 1018 
T K E Q E S E [ ]  L S N L M N T Y L N M W 292 
AT GAACAGGATGGATAAAGGTAAGCAGAAT CC GATAGGCGCT CAT TAAGGT TCT CAGGA 1078 
M N R M D K G K Q N P D R R S L R F S G 312 
AAAGAACTT GACC CTGAAGC TAT T TAT CAGT T GAT TGATAT AT C CAGAAAT T TACAAAT C 1138 
K E L D P E A I Y Q L l D I S R N L Q I 332 
CC T CCT GAC~AT CT T AT TGATATGCTAAGGGAT GAAGATGGCAGGAAGT T GGTGGAAGA ] 198 
? P E D L [ D M L R O E D (3 R K F G C, 8 352 
T TAGAAT CTGAAA GAAG T T GATGT T CCCTTGGAC CTGGAT GAGG TAACC3GAGACTAT G 1258 
L E S E K E V D V P L D L D 8 V T E T M 3"72 
ACTGATAAAACAAATGTAT ATAAAAACAAACAAGGCT T TG TAAGGCAACCTACAT CCCCG 1318 
T D K T N V Y K N K Q G F V R Q P T S P 392 
GT CCTGCCCAATAT CCCTGAAGGCCT ACAGT TGAAGATATGGTGAAT CT TATGGGGGCT 1378 
V L P N I P E G L T V E D M V N L M G A 412 
GATAAG T TACAAAAT CGAT T T AAACAAAATAAT GGAT TGCAAAGACC TACC CTAT GCT T 1438 
D K L Q N R F K Q N N G L Q R P Y P M L 432 
AGCAAAATAAAGGGACACAAAGCTAT TTGGCCCAAAGAAT CTGAAAAGAGGCAAAT TGAG 1498 
S K I K G fl K A I W P K E S E ~ Q I 8 452 
TAT GAAT CAAGGCCTGAAAAAGAGGAGGAACTAGCAGAT TATGTAGTAAAGATGCTAGCT 1558 
Y E S R P E K E E E L A D Y V V K M L A 472 
AAATACC CAGAGCTTT TAGGTAACAAT CAAAACAAAAAAATGCCCAT T CCT TATT CTGCA 1618 
K Y P E L L G N N Q N K..~K M P I P Y S A 492 
~ A T  CT T CAGGAGCTAGAAAAGCAATATGAGAATGCT TTAAGAGGATATGT GAATATG 1678 
G D L Q E L E K Q Y E N A L R G Y V N M 512 
CGTGGT TATCAGGAT TTAGAGACAGT T CCAGCAGTAACCGAAGGCTGT CGACCAGGGAA 1738 
R G Y Q D L E T V S S S N R R L S T ;~ E 532 
AATGACGAT ACACAGAACAAG CAGTATATAGATGAGGACT TGCT TATGAAAGT CTT GGAA 1798 
N D D T Q N K Q Y I D E D L L M K V L E 552 
TAT CT GAAT CAAGAGAAAG CAGAAAAAGCAAGAGATCACAGTGT TAAAAGAT CTATGGAA 1858 
Y L N Q E K A E M A R D H S V ~ S M E 572 
AATATGTAAATTTTTGCATTATTCAACTCCATCAATATATTTTTTTTGCTCTGTTTTTGT 1918 
N M 574 
TCTTCTTGCTTTAACTTAGTGAATGAAGCCAAGGCCCTTCATTCACTAACGGGAATATTC 1978 
ATCTGATGACCAGTTGTTAGGATGTACACAGGTTAATCATCCATGTTCATCAAAGTAGTA 2038 
AAATTATATTTTTATCCACTAAATACTTTTATACATTTGAGGACATTTGAAGTCACTGAA 2098 
AATCTGTTTTTTTCCTGAATTTAAAAGTGCCCGATTACATTATTCAGAAATCTATATAAC 2158 
CCGTATTATTTTCTCAATGACTCTTTCGTTTTTTTGTTACTTCTAAAAGTTTGAGATCTA 2218 
TTTATGATAAAATTATAAAAATTGTACTTTACATTATTGTTAATTAGTGGATCTTTGGTA 2278 
GAAAAGAGAAATGTGTATTCAAGCATGAAATAATGAACTGCAAGCATTGTTCCTAAAGAA 2338
GTGTTATGAGTGAGGAAAATGTGAATATGGTTTTCATGTAGAGCATCTATGAAGTGAGCC 2398 
CACTAAATTGGAATAATTTATTTCTACTAAATTTTATTTTCAGCATCTCTCTTTAACAAA 2458 
TCCCAAAGGCATTTTCCATGAGATAGAAGTGCTAATGAGAAACATTATTACAGGTTTCAC 2518 
TTCAGTTCATATGTCCACTATTCTATCCATCACAGATAACTTTATAATACATGTGAAC~qA 2578 
TGTACTGGAGCCCAAAGTGTAAATGATAAATACTTTGATAATTATGAATATATATTATAA 2638 
C~CAAATAACAGTACAAAGTTCAGTAAACATTTGCAACTAGT .... 3' 2680 
Fig. 1. Nucleotide sequence and deduced amino acid sequence of 
Rana ridibunda SglI cDNA. The predicted preprotein is in single let- 
ter amino acid code and is numbered on the right along with the 
nucleotide sequence. The N-terminal Ala residue of the mature pro- 
tein is underlined in bold. The 11 pairs of basic amino acids are un- 
derlined, the potential sulfation site is circled and the potential N- 
glycosylation site is boxed. 
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MS SQRNYCLAGCL S S C I LV ILMS FSDAAS FQYYQVPQQDQEYRMKTLQRL P S PE~LKALE 33 
-~-GAA- -L IP - IF - I -GAE . . . . .  RN-LL  -~PDL -LENV-KF-  - -E -  IR -  - - 
- ~ -  GAV-  -L IP - IF -L -EAr  . . . . .  RN-LL  -KEPDL -LENV-  -F -  - -E - IR - - -  
-TESEA-RFGAV-LL  ~-  I F -VPGTE . . . . .  RN-LL  -KEPDL -LENV-KF-  - -E -  IR -  - - 
-AGAEA-R-GAV-LL  IH -  I F -  I -GAE . . . . .  RN-LL  -KEPDL -LENV-KF- - -E -  IR - -  - 
Y I ENL  RKQAS P~TE S L PDYT S YQ GAP FL  S EQKDT QAL  S T DTAKS PT  S DDE S E~AML EAL  93 
. . . . . .  Q -  -HE~-  - S - - -NP-  - -VSVPLQ- -ENGDE-HLP~. .  . RD -LS  -ED-  - - I I . . . .  
- - -K - -Q- -HKE- -S - - -NP- - -VSVPLQ- -ENGD. . .  LPES-RD-LS-D- - -K I IA - - -  
- -  -K - -Q-  -H -E - -S - -  -NP-  - - I SVPLQ - -ENGEZ-HLAES -RDVL S -D  . . . .  I I  . . . .  
- - -K -  -Q  - -H -E  - - S - - -NP  - - -VSVPLQL -EMCEE -HLAE S -RDAL S - D . . . .  I I . . . .  
M~9~/~AKVS PQE. .  E~LYMDKNI  PPEL  IEDYD SNEWSEKRPEAGKFS SRLYDDYSRDN 151 
R- - -N-PQSA-K-NKPYA-NSE- -F -MDMSD- -ETQQ-P-R I~-~- .  PPM-EEN . . . .  
R - - -N -PQSA-K-NKPYT-NSE- -F -MDMPD . . . .  QQ-A-RKL-HMR- .  PPM-EEN . . . .  
R - - -N -PPSALK-NKPYA-NLE- -F -VDTPD- -ETQQ-P-RKL- I~R- .  PLM-EEN . . . .  
R - - -N -PPSA-K-NKPYA-NLE- -F -VDTPD- -ETQQ-P-REL-HMR-  . PLM-EEN- -E -  
PL~NEIVmGQYTPQ SLATLQSVf fQEL  GE~K~P~RMEEDQ~YEDDEDDLYEAN 211 
-F  . . . . . . . .  E . . . . . . . . . .  E . . . . . . . . .  T -PN-Q- -E - -D-E  . . . .  T . . . . .  T . . . .  
- F  . . . . . . . .  E . . . . .  N . . . .  E . . . . . . . . .  T -PNSQ- -E -AD-E  . . . .  T . . . . .  I . . . .  
- F  . . . . . . . .  E . . . . . . . . . .  E . . . . . . . . .  T -PS-Q- -E -VD-E  . . . .  T . . . . .  V - -T -  
-F  . . . . . . . .  E . . . . . . . . . .  E . . . . . . . . .  T -PS-Q- -E -VD-E  . . . .  T . . . . .  V - -T -  
N IAYEDVAGGEI~NP I EEKVE SQTQEELKE SQEEVEKTDDMEDE I KRS GL  L GLQDEEPEK 271 
. . . . . . .  V . . . . . . .  V - -  - I  . . . . . . .  VRD-K-N I  G-NEQIN-  -M . . . .  Q - - I  -E -DLR-  
. . . . . . .  V . . . . . . .  V - - - I  . . . . . . .  VRD-K-NAD-  -F~ IN- -M . . . .  Q . . . . . .  DLR-  
. . . . . . .  V . . . . .  S -M- - - I -T  . . . . .  VRD-K-NT  - -NEQINE-M . . . .  H - - -P - -GNR-  
. . . . . . .  V . . . . .  S . . . . .  I -T  . . . . .  VRD -K -NT  - -NEQINE-M . . . .  Q - - -P - - -NRR 
DTKEQESENL S N I a 4 N T Y L ~ K G K  , QN . PD . RRSLRF  S GKELDPEAIYQL  ID I  S R 328 
ES-D-L -DDV-KVI .  A -  -KRLV-AAGS -RL  - -GQNGE-AT  - -FE -P - -  SQ S . . . . .  E - - -  
ES  -D  -LLDDV-KVI .  - - -KRLV-AAGS -RS  - -GQTGE-AT-LFE-P -  - -QS  . . . . .  E - - - 
ES -D-L - -DA-KV I  . - - -RRLV-AVGS -RS  - SGQNGD-AA-LLERP - - SQS . . . . .  E - - -  
ES  -D-L  - -DA-  KV I  . - - -RRLV-AVGS -RS  - SG-NGD -AA-LLQ-P -  - SQS . . . . .  E - - - 
NLQ I PPEDL IDMLRDEDGRKFC~RLE SEKEVDVPLDLDEVTET I~DKT~ . . . .  QG 384 
. . . . . . . . . .  E - -K . .  T -E -PN-SV-P -R-L -L -V - - -D IS -ADL-H~DLFQ-RMLSKS-  
. . . . . . . . . . . . .  K . .  T -E -P . . .  V -  P -Q-LE I  -VEPED I S -VDL-HPDLFQ-  -ML  SEN-  
. . . . . . . . . .  E - -K .  . A -E -  PN-LV-P -QDLELAV- -  -D IP -ADI  -RPDMFQS-TL  SKG-  
. . . . . . . . . .  E - -K .  . A -E -PN-LV-  P -QDLELAV- -  -D I  P -ADL-RPDMFQS -ML  SKG-  
FVRQPTSPVLPNIPEGLTVEDMVNI~G . . . . . . . .  ADKLQNI tFKQNNGLQR.  PYPML.  SK  434 
YPKT  -GRAGTEAL-D - -S - - - I L -  - L  -ME SAANQKT SYFP  - PYN - EKV-  P -L  - -GAGR-R  
YPKA-  GHA-AEAL  . . . .  S - - - I L - - L  -MESAANPKPPYFP  -QYNREKV-  S -L  - - GPGR-  - 
YPEA-  GRG~MEAL -D-  -S -  - - I  x. -VL  -MENVANQKS PYFP  - QY  SRDEA-L  -L - -GPGK-R  
YPKA-  GRGMVEAL -D- -S - -  - IX. -VL  -MENVVNQKS PYFP  -QYS -DKA-M-L  - -GPGK-R  
• IKG}~AIWPI~SEKRQIEYESRPEKEEELADYVVEMLAKYPELLGNNQNKKMPIPYSAG 493 
SNQL P - -A -  I PHV-N-  -MA-  -NLND - DQ - - GE  - LAR-  -V  . . . .  I INS  - -V -RV-  GQG-  SE  
ANQL P - -V - I~DV-N - -MA-  -NLND -DQ - - GE  -LAR-  -V  . . . .  IMNA-  PA-RV-  SQG-TE  
ANQIP -VA-  IPDV-  S - -AP  -DNLND-DQ-  -GE  -LAR-  -V  . . . . .  MNT - - L  -RV-  S -G-  SE  
ANQ IP  -VA-  IPDV-  S - -AP  - -NLND . . Q - -GE-LAR-  -V  . . . . . .  NT  - - L  -RV-  S -V -  SE  
• DLQELEKQYENALRGYVNMRGYQDLETVSSSN!RR.  . LSTRENDDTQNKQYIDEDLLMKV 550 
D . . . .  E - .  - I -Q -  IKEHL  -QGS S -ETDKLAPVSK-  FPVGPPK . . . .  P -R - -W . . . . . . . .  
D -R-DEN.  - I -Q -  -KEHL  SQHS S -ETDKLA-VSK-LPVG-PKS - - -P -RP-L  . . . . .  V - -  
D . . . .  E - .  -X.-Q- IKEHLGQGS S -EM-KLAKVSK-  I PAGSLK-E - -P -R -  -X. - - -M-L - -  
D . . . .  E - .  - L  -Q-  IKEHLGPGS S -EM-KLA/ fVSK- IPVGSLK-E  - -p -R - -T .  - -  -M-L -  - 
m 
Frog  L EYLNQEKAEKARDHSVKRSMENM 574 
Human . . . . . . . . . . .  G -E - IA - -A  . . . .  
Bov ine  . . . . . . . . . . .  G -E -LA- -A  . . . .  
Rat  . . . . . . .  Q - -QG-E-LA-  -A  . . . .  
Mouse  . . . . . . .  Q - -QG-E-LA- -A  . . . .  
Fig. 2. Alignment of the amino acid sequence of frog Sgll with those of human [21], bovine [20], rat [27] and mouse [28] SglI. Identical amino 
acids between the frog Sgll sequence and the other sequences are indicated by dashes. The dots in the sequences indicate gaps introduced for 
the alignment purpose. The numbers on the right correspond to the frog SgII amino acids. The bold lines above the frog Sgll sequence indicate 
the dibasic sites and the boxed sequence corresponds to frog secretoneurin [6]. 
mals has revealed the occurrence of nine pairs of basic amino 
acids [1,2] which can be processed in vivo to generate bioac- 
rive peptides uch as SN [9]. Frog SglI contains eleven pairs of 
basic amino acids (Fig. 1), seven of which are common to 
mammalian and frog SgII. The additional pairs of basic res- 
idues found in frog SglI correspond to single basic amino 
acids in the mammalian sequences (Fig. 2). The alignment 
of the frog and mammalian proteins hows an overall identity 
of 46A8%, several regions being more conserved than others. 
In particular, four peptide sequences delimited by conserved 
dibasic cleavage sites possess a high degree of structural iden- 
tity (Fig. 3). Among these peptides, SN (denoted by number II 
in Fig. 3) exhibited the highest sequence conservation across 
species (82% identity between the frog and human peptides). 
Previous studies have shown that SN is actually processed in 
the frog [6] and bovine brain [9] and this peptide has been 
found to stimulate dopamine release t¥om the rat striatum 
[10,11]. Three other putative peptides denoted by numbers 
III, V and VI in Fig. 3 also exhibited a high degree of se- 
quence conservation (68, 70% and 80% identity between the 
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frog and human SglI sequences, respectively). The rat coun- 
terpart of peptide number V, named LA-42, has been pre- 
viously isolated from pituitary gonadotroph-conditioned me-
dium [7] while the bovine counterpart of peptide number VI 
has been characterized from purified secretory granules of 
adrenal chromaffin cells [8]. It has also been found that this 
latter peptide was released from cultured bovine chromaffin 
cells, together with catecholamines, upon nicotinic stimulation 
[8]. The strong conservation of these four peptides from am- 
phibia to mammals and the fact that three of them have al- 
ready been characterized in tissue extracts and/or culture me- 
dia support he concept hat SglI may serve as a precursor for 
several regulatory peptides. In contrast, two other peptides 
(numbered I and IV in Fig. 3) are unlikely to occur as free 
regulatory peptides since their sequences are poorly con- 
served. In fact, there is evidence that peptide number I is 
not formed in vivo [9,22]. 
3.3. Distribution of  the Jrog SgI1 mRNA 
Expression of the frog SglI gene in different tissues was 
studied by Northern blot analysis. A strong hybridization 
signal corresponding to an mRNA of ,~4 kb was observed 
in the brain, hypothalamus, pituitary and spinal cord. In the 
adrenal gland, the concentration of SgII mRNA was much 
lower (Fig. 4). No signal could be detected in liver, spleen 
or testis (data not shown). These data confirmed the larger 
size of the frog SgII mRNA (~4 kb) compared to mamma- 
lian SgII mRNA (2.5 kb) and the neuronal- and endocrine- 
specific expression of the frog SgII gene as previously reported 
in mammals [2]. The molecular mechanism underlying the 
restricted expression of the SgII gene is still unknown. How- 
ever, a functional cAMP-responsive element has been recently 
characterized in the mouse SgII promoter [23]. This cis-regu- 
latory element might also confer, alone or in combination 
with other cis-acting element(s), tissue-specific expression to 
the SgII gene as was shown for another member of the granin 
family, CgA [24,25]. 
In situ hybridization histochemistry evealed the widespread 
distribution of the SgII mRNA in the frog brain. In the tel- 
encephalon, prominent hybridization signal was found in the 
pallium and the amygdaloid complex (Fig. 5A). In the dien- 
cephalon, a strong signal was observed in the anterior preop- 
tic area, the dorsal and ventral hypothalamic nuclei and the 
posterior thalamic nucleus (Fig. 5A,B). In contrast, other re- 
gions such as the medial septum, the lateral thalamic nucleus 
and the optic tectum only showed a low hybridization signal 
(Fig. 5A,B). At a high magnification, it appeared that, in the 
brain regions which exhibited intense labeling, several cells 
strongly expressed the SgII gene while other cells were totally 
t~ It~ tit ~ I iV ~: V~Vt 
I I I II 
40% 82% 68% 30% 70% 80% 
Fig. 3. Schematic representation of the structure of SglI showing 
the conservation of processing sites and sequences between frog and 
human SglI. The numbers in parenthesis refer to the position of the 
pairs of basic amino acids and the roman numbers designate the 
peptides which can be potentially generated from the processing of 
these dibasic sites. The hatched zone corresponds to secretoneurin 
[6,9]. The percentage of amino acid identity between the frog and 
human sequences are indicated under each putative peptide. 
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Fig. 4. Northern blot analysis of frog Sgll mRNA. Approximately 
the same amounts of total RNA (20 gg) from different issues were 
hybridized to the 32p-labeled random-primed RFSN3 probe and ex- 
posed to X-AR5 film for 10 days with intensifying screens. Riboso- 
mal 28S and 18S RNA positions are indicated in the left margin. 
devoid of SgI1 mRNA (Fig. 5C,D). The differential expression 
of the SglI gene in various regions of the brain as previously 
reported in rat [26] and in discrete cells within each region, 
strongly suggests that SglI and/or its processing products may 
play an important role in the regulation of neuronal activity. 
In conclusion, the characterization f the frog SglI cDNA 
has revealed the existence of four peptide sequences, in the 
SglI protein, which have been highly conserved uring evolu- 
tion. These data, together with the differential expression of 
the SglI gene in the brain and endocrine tissues, support he 
view that SglI may serve as a precursor for biologically active 
peptides. 
3.4. Note added in proof 
Holthuis and Martens [30] have recently described the clon- 
ing of a cDNA encoding the SgII of Xenopus laevis, which 
also exhibits a high regional conservation with the mamma- 
lian SgII. 
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